Small Pharma Phase II/III CRO Benchmarking Market Report 2021: Discover the CRO Attributes Driving Outsourcing Choices for Phase II/III Clinical Research

News provided by

Jul 08, 2021, 17:45 ET

DUBLIN, July 8, 2021 /PRNewswire/ -- The "Phase II/III CRO Benchmarking - Small Pharma Market (2nd Ed.)" report has been added to ResearchAndMarkets.com's offering.

The publisher understands the desire for a deeper dive into the small and emerging biopharma landscape. Are the needs, perceptions, and interactions of this segment different compared to the wider audience of Phase II/III clinical development outsourcers?

In a word, yes. The goal, therefore, of this small and emerging biopharma report is two-fold. First, this research will help small and emerging biopharma companies make more informed CRO selection decisions. Second, these findings will help CROs optimize operational and marketing strategies to better accommodate small and emerging biopharma companies.

As these companies continue to increase their role in drug development and innovation, the publisher knows the importance of keeping a pulse on this subset. Our goal remains the same-provide quality market research to ensure both sponsors and providers can glean what they need to make the best decisions possible for their clinical development programs and service offerings.

What You Will Learn:

Small & Emerging Sponsors:

Make smarter CRO outsourcing decisions by learning which service providers line up with your company's needs
Discover the CRO attributes driving outsourcing choices for Phase II/III clinical research, as well as which attributes are increasing in importance over the last 12 months among industry peers
Find which CROs have the highest customer loyalty scores - as determined via customer satisfaction, willingness to recommend, and likelihood to use again ratings

Service Providers:

Refine your marketing efforts by focusing on what customers say makes your organization stand out to small & emerging biopharma companies
Uncover the factors influencing small & emerging sponsor outsourcing preferences, and which factors are increasing in importance for future outsourcing

Major Topics:

Service Provider Selection Process
Service Provider Perceptions and Interactions
Study Data
Demographics

Key Topics Covered:

1. Service Provider Selection Process

Primary Section Takeaways
Preferred Provider Agreements
Number of Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance
No Preferred Providers
Use of Outside Consultants
Respondent Comments

2. Service Provider Perceptions and Interactions

Primary Section Takeaways
Leadership, Familiarity, and Use
Service Provider Preference
Service Provider Preference among Users
Cost Perceptions
Cost Experience among Users
Summary Table
CRO Loyalty
Respondent Comments

3. Study Data

Phase II/III Leaders, Unprompted
Phase II/III Leaders, Prompted
Service Provider Familiarity
Service Provider Familiarity - Additional Providers
Service Provider Usage
Service Provider Preference
Service Provider Differentiation
Service Provider Cost Perceptions
Use of Preferred Providers
Number of Preferred Providers
Selection Drivers: Selecting among Preferred Providers
Preferred Provider Attributes Gaining Importance
Selection Drivers: When Not Using Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance:
No Preferred Providers
Use of Outside Consultants
Outside Consultant Assistance

4. Demographics

Company Type
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Outsourcing Involvement by Phase
Involvement in Clinical Development
Therapeutic Areas of Responsibility
Years of Industry Experience
Age
About the Publisher

For more information about this report visit https://www.researchandmarkets.com/r/m2zsg9

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets